Wikidata

(Q40172029)

English

TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response.

scientific article published on 19 September 2007

In more languages

Statements

title
TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17884184
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17884184%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40172029&oldid=2083269228"